More from Investing
Micron is motivating more positive outlook on the semiconductor sector's road ahead.
The drop in AbbVie's stock price following revelation of its plans to buy Allergan provides a way to hit a solid investment single using a buy-write options strategy.
Let's check the charts this morning ahead of the open, imagining strength to the $35.50 area.
The retailer's charts are sending bullish and bearish signals, so it could trade in a range for a bit.
With the likelihood of some news on U.S.-China trade over the weekend, it is going to be tough for both bulls and bears to do much for the remainder of the week.